Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
Sign Up to like & getrecommendations! Published in 2019 at "Italian Journal of Pediatrics"
DOI: 10.1186/s13052-019-0737-4
Abstract: Severe asthma has a substantial epidemiological impact on children and biological treatments can be an option to take into account, as they target specific molecules and pathways involved in its pathogenesis. Modern medicine is continuously… read more here.
Keywords: mepolizumab landscape; biological therapy; omalizumab mepolizumab; severe asthma ... See more keywords